Mark E Kutner
Target (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, Diabetes, Cardiovascular Risks, and Lipoproteins, COVID-19 Clinical Research Studies
Most-Cited Works
- → Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial(2018)774 cited
- → Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial(2021)602 cited
- → Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension(2023)168 cited
- → Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial(2021)137 cited
- → Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine(2021)59 cited